NEIL KOBROSKY, MD
Endocrinology, Diabetes & Metabolism Physician in GLOUCESTER, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
NEIL KOBROSKY, MD reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 7,236 Medicare Part D claims in 2023.
- 75/100
- MIPS score · -8 vs avg
- 7K
- Part D claims, 2023
- 61%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
NEIL KOBROSKY, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
NEIL KOBROSKY, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about NEIL KOBROSKY, MD?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Massachusetts
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Massachusetts providers
Endocrinology, Diabetes & Metabolism Physician share within Massachusetts
Endocrinology, Diabetes & Metabolism Physician is one of the more visible NUCC categories in Massachusetts
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
NEIL KOBROSKY, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 75/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Specialty volume Endocrinology, Diabetes & Metabolism Physician US NPIs
75/100 MIPS final score — 8.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Endocrinology, Diabetes & Metabolism Physician.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
NEIL KOBROSKY, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 298 WASHINGTON ST, GLOUCESTER, MA, 01930, with a listed phone of (978) 283-4000. NPI 1558308205 was issued on 06/01/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KOBROSKY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 7,236 prescription claims written by this provider, covering 1,055 Medicare beneficiaries and totaling roughly $3.1 million in drug spend, split 39% brand-name and 61% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1558308205 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 06/01/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm NEIL KOBROSKY, MD's current license status, disciplinary history, and board certifications with the Massachusetts Board of Registration in Medicine in Massachusetts before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
License & disciplinary context — Massachusetts BORIM 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to NEIL KOBROSKY, MD. To verify NEIL KOBROSKY, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
39% brand-name claims vs 61% generic, on 7,236 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 17,446
- Total Day Supply
- 519,420
- Brand vs Generic
- 39% brand / 61% generic
- Brand Drug Cost
- $2.9M
- Generic Drug Cost
- $119K
- Antibiotic Claims
- 17
Patient Demographics
- Average Patient Age
- 72.7 years
- Avg HCC Risk Score
- 1.37
- Gender Split
- 65% female / 35% male
- Age Distribution
- <65: 129, 65-74: 463, 75-84: 378, 85+: 85
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What NEIL KOBROSKY, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
1,383 claims
- Glipizide Er
Glipizide Er
584 claims
- Metformin Hcl Er 534
Metformin Hcl Er
534 claims
- Trulicity 528
Trulicity
528 claims
- Synthroid 217
Synthroid
217 claims
- Metformin Hcl 137
Metformin Hcl
137 claims
- Testosterone Cypio… 118
Testosterone Cypionate
118 claims
- Methimazole 117
Methimazole
117 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 1,383 |
| Glipizide Er Glipizide | 584 |
| Metformin Hcl Er Metformin Hcl | 534 |
| Trulicity Dulaglutide | 528 |
| Synthroid Levothyroxine Sodium | 217 |
| Metformin Hcl | 137 |
| Testosterone Cypionate | 118 |
| Methimazole | 117 |
| Alendronate Sodium | 116 |
| Liothyronine Sodium | 112 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Endocrinology, Diabetes & Metabolism Physician Overview
How NEIL KOBROSKY, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
NEIL KOBROSKY, MD's 7,236 claims are above the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as KOBROSKY.
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Massachusetts
Frequently Asked Questions
What is NEIL KOBROSKY, MD's specialty? ▼
How much does NEIL KOBROSKY, MD prescribe under Medicare Part D? ▼
What is NEIL KOBROSKY, MD's Medicare quality score? ▼
Where is NEIL KOBROSKY, MD located? ▼
What is NEIL KOBROSKY, MD's NPI number? ▼
Does NEIL KOBROSKY, MD prescribe more brand-name or generic drugs? ▼
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
What drugs does NEIL KOBROSKY, MD prescribe most often? ▼
Does NEIL KOBROSKY, MD accept Medicare? ▼
How can I verify NEIL KOBROSKY, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology